(Q38086042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

MRI for response assessment in metastatic bone disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

F E Lecouvet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

A Larbi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

V Pasoglou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

B Tombal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

N Michoux

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

J Malghem

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

R Lhommel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

B C Vande Berg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

1 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1986-1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23455764%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00330-013-2792-3

24 February 2020

exact match

0 references

cites work

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Imaging metastatic bone disease from carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Bone imaging in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Multiple myeloma: MR patterns of response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Imaging response to systemic therapy for bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Normal variants and frequent marrow alterations that simulate bone marrow lesions at MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Whole-body MRI for the staging and follow-up of patients with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Magnetic resonance imaging of bone marrow in oncology, Part 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

MR imaging of bone marrow in children with osteosarcoma: effect of granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Diffusion MR imaging for monitoring of treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Diffusion-weighted MR imaging: adjunct or alternative to T1-weighted MR imaging for prostate carcinoma bone metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Diffusion-weighted magnetic resonance imaging and its application to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Bone metastases: assessment of therapeutic response through radiological and nuclear medicine imaging modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Measurement of perfusion and permeability from dynamic contrast-enhanced MRI in normal and pathological vertebral bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Evaluation of New Sclerotic Bone Metastases in Breast Cancer Patients During Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Early Response of Breast Cancer Bone Metastases to Chemotherapy Evaluated with MR Imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-013-2792-3

Response evaluation of bone metastases in breast cancer: value of magnetic resonance imaging

21 January 2018

1 reference

12 December 2020

Evaluation of new sclerotic bone metastases in breast cancer patients during treatment

1 reference

12 December 2020

Treated plasma cell lesions of bone with MRI signs of response to treatment: unexpected pathological findings

1 reference

12 December 2020

Assessing response in bone metastases in prostate cancer with diffusion weighted MRI

1 reference

12 December 2020

The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

1 reference

12 December 2020

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

1 reference

12 December 2020

Magnetic resonance imaging of the bone marrow in hematological malignancies

1 reference

12 December 2020

Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases

1 reference

12 December 2020

Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa)

1 reference

12 December 2020

Early response of breast cancer bone metastases to chemotherapy evaluated with MR imaging

1 reference

12 December 2020

Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases

1 reference

12 December 2020

Diagnosis of skeletal metastases and assessment of response to treatment.

1 reference

12 December 2020